Benefits of biomarker selection and clinico-pathological covariate inclusion in breast cancer prognostic models
-
* Corresponding author: Yuval Kluger yuval.kluger@yale.edu
- Equal contributors
Breast Cancer Research 2010, 12:R66 doi:10.1186/bcr2633